Evidence map›Paper›PMID 32674290›Full record

ArticleInternational journal of molecular sciences2020

Loss of Dystroglycan Drives Cellular Senescence via Defective Mitosis-Mediated Genomic Instability.

Guadalupe Elizabeth Jimenez-Gutierrez, Ricardo Mondragon-Gonzalez, Luz Adriana Soto-Ponce, Wendy Lilián Gómez-Monsiváis, Ian García-Aguirre, Ruth Abigail Pacheco-Rivera, Rocío Suárez-Sánchez, Andrea Brancaccio, Jonathan Javier Magaña, Rita C R Perlingeiro and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Analysis of Beta-Dystroglycan in Different Cell Models of Senescence.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Guadalupe Elizabeth Jimenez-GutierrezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.ORCID 0000-0003-0301-9121
Ricardo Mondragon-GonzalezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.
Luz Adriana Soto-PonceDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.
Wendy Lilián Gómez-MonsiváisDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.
Ian García-AguirreDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.
Ruth Abigail Pacheco-RiveraDepartamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.
Rocío Suárez-SánchezDepartamento de Genética, Laboratorio de Medicina Genómica, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Ciudad de México 14389, Mexico.
Andrea BrancaccioSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0003-4690-8826
Jonathan Javier MagañaDepartamento de Genética, Laboratorio de Medicina Genómica, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Ciudad de México 14389, Mexico.ORCID 0000-0003-4399-4618
Rita C R PerlingeiroDepartment of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0001-9412-1118
Bulmaro CisnerosDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico.
Instituto Politécnico Nacional · MXInstituto Nacional de Rehabilitación · MXUniversity of Bristol · GBUniversity of Minnesota · US

Funding

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional CNR2018/4Consejo Nacional de Ciencia y Tecnología 442402NIH HHS R01 AR055299 and AR071439
6 · The paper itself

Abstract

Nuclear β-dystroglycan (β-DG) is involved in the maintenance of nuclear architecture and function. Nonetheless, its relevance in defined nuclear processes remains to be determined. In this study we generated a C2C12 cell-based DG-null model using CRISPR-Cas9 technology to provide insights into the role of β-DG on nuclear processes. Since DG-null cells exhibited decreased levels of lamin B1, we aimed to elucidate the contribution of DG to senescence, owing to the central role of lamin B1 in this pathway. Remarkably, the lack of DG enables C2C12 cells to acquire senescent features, including cell-cycle arrest, increased senescence-associated-β-galactosidase activity, heterochromatin loss, aberrant nuclear morphology and nucleolar disruption. We demonstrated that genomic instability is one driving cause of the senescent phenotype in DG-null cells via the activation of a DNA-damage response associated with mitotic failure, as shown by the presence of multipolar mitotic spindles, which in turn induced the formation of micronuclei and γH2AX foci (DNA-damage marker), telomere shortening and p53/p21 upregulation. Altogether, these events might ultimately lead to premature senescence, impeding the replication of the damaged genome. In summary, we present evidence supporting a role for DG in protecting against senescence, through the maintenance of proper lamin B1 expression/localization and proper mitotic spindle organization.

Indexed as

Amino Acid SequenceAnimalsBase Sequencebeta-GalactosidaseCell Cycle CheckpointsCell LineCell NucleusCellular SenescenceCyclin-Dependent Kinase Inhibitor p21DNA DamageDystroglycansGenomic InstabilityHistonesLamin Type BMiceMice, Knockoutbeta-GalactosidaseCyclin-Dependent Kinase Inhibitor p21DystroglycansHistonesLamin Type BTumor Suppressor Protein p53cellular senescencedefective mitosisDNA-damage responselamin B1β-Dystroglycan

Identifiers

PMID32674290
PMCPMC7404207
OpenAlexW3042258603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.